glp 1 agonist and depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] Targeting the GLP-1 receptor pathways

The first week on a new GLP-1 establishes your baseline response

Other therapies were linked to increased adverse events such as stroke [11], hyperkalemia [13,15], hypotension [13], acute kidney injury (AKI) [15], and major adverse cardiovascular events (MACE) [14]

10.3810/pgm.2011.07.2305 100 KimS

For the successful clinical implementation of these newly developed multiple hormone receptor agonists, it is essential to elucidate their fundamental mechanisms of action, and at the same time to confirm their efficacy and safety in real-world applications

As the potential uses of these drugs expand, such as with recent approvals to prevent heart attacks and strokes in adults with cardiovascular disease who are overweight, the high cost and increased demand for these drugs may increase health spending